AirFluSal MDI

Images for illustrative purposes only

AirFluSal MDI is a combination inhalation treatment used for the long-term management of asthma and chronic obstructive pulmonary disease (COPD) containing the active ingredients salmeterol and fluticasone propionate.

  • Contains both a preventer steroid and a long-acting bronchodilator for dual-action airway management
  • Designed to provide continuous respiratory support for up to 12 hours with regular use
  • A widely prescribed MDI (Metered Dose Inhaler) used across the NHS for chronic asthma and COPD
  • Fulfilled by Mail my Meds and delivered discreetly to your door following a clinical review
In Stock
Discreet Packaging
Prescription included
Quick & Easy
£30.99 
You will need to answer a few questions about your health before completing purchase of this item.

More information